0% found this document useful (0 votes)
55 views22 pages

Overview of Urinary System Drugs

Uploaded by

Francis Chege
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
55 views22 pages

Overview of Urinary System Drugs

Uploaded by

Francis Chege
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPTX, PDF, TXT or read online on Scribd

Drugs acting on

Genitourinary System
Dip. Clinical Med:2.2
KMTC MWINGI
MR. NYAMAI S.M
Urinary antiseptics
 are oral agents that exert antibacterial activity in the
urine but have little or no systemic antibacterial effect.
Their usefulness is limited to lower urinary tract
infections.

 Nitrofurantoin
At therapeutic doses, nitrofurantoin is bactericidal for
many Gram-positive and Gram-negative bacteria;
however, P aeruginosa and many strains of Proteus are
inherently resistant.
 Nitrofurantoin has a complex mechanism of action that
is not fully
Drugs used on Urinary System
Classified into;
• Urinary Antiseptics.
• Antidiuretics.
• Cholinergics & Anticholinergics.
• Acidifiers & Alkalanizers.
Urinary Antiseptics
Drugs used for urinary tract infects which kill
or inhibit the growth of microorganism.

Attain antibacterial concentration only in


urine. There4 no systemic antibacterial
effect
Include:
Nitrofuratoin
Methenamine
nitrofuratoin
 Primarily bacteriostatic in high urine conc its
bacteriocidal(its activity enhaced in lower PH)
Mode of action:
Taken by susceptible bacteria, enzymatically
metabolized to produce intermediates that
damage DNA and protein synthesis.
Activity currently restricted to E.coli
Does not develop resistance during continued
therapy.no cross resistance with other anti
microbials known
It antagonizes bactericidal action of Nalidixic Acid
pharmacokinetics
 Well absorbed
 Rapidly metabolized in liver
 Less than half excreated in urine unchanged
 T1/2 30min-60mins
 Renal excreation reduced in Azotemia pt: NOT
used renal failure due to accumulation in body
 Probenacid inhibits its tubular
secretion:reducing its antiseptic action in
urine
 Contraindicated in neonates,pregnacy 38-
42wks,renal failure
Adverse effects
 GI-intolerance;nausea
vomiting,diarrhea,abd pains
 Fevr,chills,leucopenia occasionally
 Longterm use:peripheral

neuritis/neurological effects
 In G6PD-hemolytic anemia
 Hepatotoxic/pulmonary rxn with fibrosis
 Urine turn dark brown when exposed to

light
Uses
 uncomplicated UTI
 Infections of E.coli 50mg-100mg tds x 5-

10days
 Suppressive longterm rx of lower uti
 Prophylaxis of UTI following

catheterization/instrumentation
Methenamine
 Drugs;methenamine
mandelate,methanamine hippurate
 Hexamethylene tetramine inactive in such
 Decomposes in urine to release
formaldehyde-inhibits bacteria
 Acidic urine is essential for its action ph<5.5
 Thus administered with organic acid e.g
mandelic,hippuric or ascorbic acid
 Adm as enteric coated tabs to protect from
gastic juices and limit fluid intake to maintain
low ph in urine
uses
 Resistant UTI not involving kidneys
 Not efective for acute UTI or

catherterization prophylaxis

 Adverse effects
 Gastritis,chemical cystitis and hematuria
Antidiuretics
Def: are the agent(s) that reduce urine
volume, opposing diuresis.
Mechanism of Action:
Reduces urine flow by acting reabsorption of
water by kidney tubules
Indication & Uses:
1. Cranial Diabetes insipidus.
2. Primary nocturnal enuresis (bed wetting)
3. Nocturia associated with multiple
sclerosis.
Ct Antidiuretics
 Drugs;
 Antidiuretic Hormone (Vasopressin) 5-10units IM/ SC
 Desmopressin 100-400mcg orally 1-4mcg IV.
 Contraindication & Precautions:
 Hypersensitivity, impaired renal function, with
ongoing diuretic treatment, Caution in CV disease,
edema, hypertension, cystic fibrosis, fluid and
electrolyte imbalance, pregnancy and lactation.
 Adverse effect: Nasal irritation, Rhinitis,
Abdominal cramps, Urge defecate, fluid retention,
congestion, Ulceration, nausea, pallor, Backache in
females (due to uterine contraction)
Acidifiers & Alkalanizers
 Urinary acidifiers;sodium citrate,pottasium
citrate,tartaric acid
 Urinary alkalanizers;sodium

bicarbonate,acetazolamide
 AntiMicrobials ;
 Acidic;Nitrofuratoin,methenamine,Tetracycli

nes,cloxacillin
 Alkaline:cotrimoxazole,aminoglycosisdes,c

ephalosporins,flouroquinolones
 PH immaterial: chloramphenicol,ampicillin
Cholinergics and
anticholinergics
 These drugs are used for retention and enuresis

 Cholinergic effect: contract detruser muscle(m3


receptor) and relaxes internal sphincter.
 Drugs: bethanechol

 Has specific affinity for cholinergic receptors of

bladder
 Indication:

non-obstructive post-op
postpartum urine retention(neurogenic bladder atony)
neurogenic bladder for children above 8yrs
 Anticholinergic effect:(inhibition of
cholinergic action)relaxation of
detruser,contraction of internal sphincter
 Drugs:oxybutynin
 Indication:
 Urine incontinence(urine involutarily leaves

bladder.
 Overactive bladder(OAB)
 Others:COPD,OPP,drooling e.t.c
Drugs acting on uterus
Stimulants
 Oxytocin
 Prostaglandin;e.g Misoprostol

Others:
 Ergometrine and Ethacridine

Relaxants/tocolytics
 Calcium channel blockers e.g nifedipine
 Beta2 agonists e.g salbutamol,terbutaline,ritodrine
 Magnesium sulphate

Others:
 Oxytocin receptor antagonist:atosiban
 Prostaglandin synthase: indomethecin, ibuprofen,asprin (beware of
premature closure of ductus arteriosus,ulceration,bleeding)
oxytocin
Not absorbed orally:administer
im/iv/intranasal/sublingual
T1/2 10-15mins
Metabolised in liver,kidney & circulating oxytocinase
Effects
 Mammary gland;Milk letdown

 Cvs-bolus injection-vasodilator-hypotension

 Kidney:antiduretic activity-water retention-water

intoxication-nausea-vomiting,anorexia,weight
gain,lethargy.
 Uterine rupture,fetal distress,maternal injury

 To curb above-always give slow infusion.


oxytocin
 Indications
 Induction/augmentation of term labor;mother&fetus must
be continously monitored
 Mild preeclampsia
 Uterine inertia
 Prevent PPH;I.M after delivery of placenta
 Missed abortion,incomplete abtn
 Post maturity
 To promote milk ejection
 Contraindication:
prematurity,hypersensitivity,breech,evidence of fetal
distress,cpd,Ecclampsia
 Precautions:multiple pregnacy,prev-c/s,hypertension
prostagladins
 Misoprostol(PGE1),dinoprotone(PGE2),carbo
prost
 MOA;contracts uterine smooth muscle
 Comparison with oxytocin
 Pgs contract uterine smooth muscles

throught pregnacy unlike oxytocin that


works better at term.
 Pgs best softens cervix than oxytocin
 Pgs have longer duration of action than

oxytocin
 Indication
 Induction of abortion
 Induction of labor(low dose)
 PPH
 Adverse effects
 Nausea,vomiting, abd pains,
diarrhea,bronchospasms,flushing
 Contraindication:CPD,fetal distress,risk of
uterine rupture(prev c/s)
 Precaution:astham,multiple pg,glaucoma,old
prev c/s
Tocolytics
 Inhibits uterine contraction/prevent premature
labor
 Indication:uncomplicated premature labor

Relaxants/tocolytics
 Calcium channel blockers e.g nifedipine

 Beta2 agonists e.g

salbutamol,terbutaline,ritodrine
 Magnesium sulphate

Others:
 Oxytocin receptor antagonist:atosiban
 Prostaglandin synthase: indomethecin, ibuprofen,asprin
(beware of premature closure of ductus arteriosus,ulceration,bleeding)
Tocolytics
 Contraindications
 Labour more than 36wks,Fetus >2.5kg,

fetal distress,cervix dilatation>4cm,


ruptured membranes,PPH

You might also like